Establishment and Characterization of FusionRed Stable Transfected Canine Prostate Adenocarcinoma and Transitional Cell Carcinoma Cells.
Alnajjar S, Nolte I, Schille JT, Sender S, Trakoolju N, Perez SV, Zechner D, Vollmar B, Junghanss C, Murua Escobar H.
In Vivo. 2022 Jan-Feb;36(1):170-179. doi: 10.21873/invivo.12688.
PMID:34972712
Intraductal Carcinoma of the Prostate Gland: Recent Advances.
Divatia MK, Ro JY.
Yonsei Med J. 2016 Sep;57(5):1054-62. doi: 10.3349/ymj.2016.57.5.1054.
PMID:27401634
Characterization of six canine prostate adenocarcinoma and three transitional cell carcinoma cell lines derived from primary tumor tissues as well as metastasis.
Packeiser EM, Hewicker-Trautwein M, Thiemeyer H, Mohr A, Junginger J, Schille JT, Murua Escobar H, Nolte I.
PLoS One. 2020 Mar 13;15(3):e0230272. doi: 10.1371/journal.pone.0230272. eCollection 2020.
PMID:32168360
Ablation of Red Stable Transfected Claudin Expressing Canine Prostate Adenocarcinoma and Transitional Cell Carcinoma Cell Lines by C-CPE Gold-Nanoparticle-Mediated Laser Intervention.
Alnajjar S, Nolte I, Becker A, Schille JT, Trakooljul N, Frank M, Ngezahayo A, Murua Escobar H.
Int J Mol Sci. 2021 Nov 13;22(22):12289. doi: 10.3390/ijms222212289.
PMID:34830170
Urothelial carcinoma of the prostate.
Palou J, Baniel J, Klotz L, Wood D, Cookson M, Lerner S, Horie S, Schoenberg M, Angulo J, Bassi P.